DEPO-MEDROL Drug Patent Profile
✉ Email this page to a colleague
When do Depo-medrol patents expire, and when can generic versions of Depo-medrol launch?
Depo-medrol is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in DEPO-MEDROL is methylprednisolone acetate. There are forty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Depo-medrol
A generic version of DEPO-MEDROL was approved as methylprednisolone acetate by HONG KONG on February 23rd, 2005.
Summary for DEPO-MEDROL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 55 |
Clinical Trials: | 120 |
Patent Applications: | 4,478 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for DEPO-MEDROL |
Drug Sales Revenues: | Drug sales revenues for DEPO-MEDROL |
What excipients (inactive ingredients) are in DEPO-MEDROL? | DEPO-MEDROL excipients list |
DailyMed Link: | DEPO-MEDROL at DailyMed |
Recent Clinical Trials for DEPO-MEDROL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Emory University | Phase 4 |
Northwestern University | Phase 4 |
Rush University Medical Center | Phase 4 |
Pharmacology for DEPO-MEDROL
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for DEPO-MEDROL
US Patents and Regulatory Information for DEPO-MEDROL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | DEPO-MEDROL | methylprednisolone acetate | INJECTABLE;INJECTION | 011757-002 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | DEPO-MEDROL | methylprednisolone acetate | INJECTABLE;INJECTION | 011757-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pfizer | DEPO-MEDROL | methylprednisolone acetate | INJECTABLE;INJECTION | 011757-004 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |